Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities
Orphazyme A/S
Company announcement
No. 03/2021
Company Registration No. 32266355
Copenhagen, Denmark, February 1, 2021 – Pursuant to the Market Abuse Regulation article 19, Orphazyme A/S, CVR no. 32266355 (“Orphazyme”), hereby notifies receipt of information of the following transactions in Orphazyme’s shares by persons discharging managerial responsibilities in Orphazyme:
1 Details of the Reporting Person / Closely Associated Person
a) Name
Anders Vadsholt
2 Reason for the notification
a) Position/status
Chief Financial Officer
b) Initial notification/Amendment
Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name
Orphazyme A/S
b) LEI code
54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where
transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code
Shares
ISIN DK0060910917
Lesen Sie auch
b) Nature of the transaction
Vesting of Matching Shares
c) Price(s) and volume(s)
Price(s) | Volume(s) | |
DKK | 1 | 17,561 |
d) Aggregated information
Aggregated volume: 17,561 shares
Aggregated price: DKK 17,561.00
Price per share (volume weighted average): DKK 1
e) Date of the transaction
February 1, 2021
f) Place of the transaction